Analysis of expression of LGALS3BP gene in thyroid tissues and peripheral blood lymphocytes in patients with papillary thyroid cancer;Analiza ekspresji genu LGALS3BP w tkance gruczołu tarczowego i limfocytach krwi obwodowej u chorych z rakiem brodawkowatym tarczycy

Endokrynologia Polska

Volumn 57, Issue SUPPL.A, 2006, Pages

  Kaliszewski, Krzysztof ^a   Łukieńczuk, Tadeusz ^a   Dobosz, Tadeusz ^a   Rzeszutko, Marta ^a   Sadakierska Chudy, Anna ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Galectin 3; Immunological system; LGALS3BP gene; Lymphocytes; Papillary thyroid cancer; Real time polymerase chain reaction

Indexed keywords

CARRIER PROTEIN; GLYCOPROTEIN; LGALS3BP PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR MARKER;

ARTICLE; COMPARATIVE STUDY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LYMPHOCYTE; MALE; METABOLISM; THYROID GLAND; THYROID TUMOR;

ANTIGENS, NEOPLASM; CARRIER PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HUMANS; LYMPHOCYTES; MALE; THYROID GLAND; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79958274926     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Sherman S. Thyroid carcinoma. Lancet 2003; 361: 501-511.
2. Leenhardt L. Indications and limits of ultrasound-guided cytology in the menagement of nonpalpable thyroid nodules. J Clin Endocrinol Metab 1999; 84: 24-28.
3. Hollman F, Hoekstra J, Ruitenberg H. Evaluation of fine-needle aspiration (FNA) cytology in the diagnosis of thyroid nodules. Cytopathology 1995; 6: 168-175.
4. Pomorski L. Rak tarczycy. W: Szmidt J (red.). Podstawy chirurgii, t. 2. Medycyna Praktyczna Kraków 2004; 1093-1099.
5. Topalian S, Rosenberg S. Tumor-infiltrating lymphocytes (TIL). Evidence for specific immune reactions against growing cancers in mice and humans. Lippincott, Philadelphia 1990; 19-41.
6. Galvan G. Punktion und Zytologie der Struma, eine Anleitung fur die Praxis. Sanabo 1983.
7. Kovacs R, Foldes J, Winkler G i wsp. The investigation of galectin-3 in diseases of the thyroid gland. Eur J Endocrinol 2003; 149: 449-453.
8. Pisani T, Vecchione A, Giovagnolii M. Galectin-3 immunodetection may improve cytological diagnosis of occult papillary thyroid carcinoma. Anticancer Res 2004; 24 (2C): 1111-1112.
9. Joo HG, Goedegebuure PS, Sadanaga N i wsp. Expression and function of galectin-3, a beta-galactoside-binding protein in activated T lymphocytes. J Leukoc Biol 2001; 69: 555-564.
10. Fusco O, Querzoli P, Nenci I i wsp. 90K (MAC-2 BP) gene expression in breast cancer and evidence for the production of 90K by peripheral-blood mononuclear cells. Int J Cancer 1998; 79: 23-26.
11. Bernet V, Anderson J, Vaishnav Y i wsp. Determination of Galectin-3 messenger ribonucleic acid overexpressionin papillary thyroid cancer by quantitative reverse transcription-polymerase chain reaction. J Clin Endocrinol Metab 2002; 87: 4792-4796.
12. Feilcheenfeldt J, Tutsch MD, Sien-Yi Shen i wsp. Expresion of Galectin-3 in normal and malignant thyroid tissue by quantitative PCR and immunohistochemistry. Modern Pathology 2003; 16: 1117-1123.
13. Hsu DK, Hammes SR, Kuwabara I i wsp. Human T lymphotrophic virus-I infection of human T lymphocytes induces expression of the betagalactoside- binding lectin, galectin-3. Am J Pathol 1996; 148: 1661-1670.
14. Calabrese G, Sures I, Pompetti F i wsp. The gene (LGALS3BP) encoding the serum protein 90K, associated with cancer and infection by the human immunodeficiency virus, maps at 17q25. Cytogenet Cell Genet 1995; 223-225.
15. Tinari N, D'Egidio M, Iacobelli S i wsp. Identification of the tumor antigen 90K domains recognized by monoclonal antibodies SP2 and L3 and preparation and characterization of novel anti-90K monoclonal antibodies. Biochem Biophys Res Commun 1997; 232: 367-372.
16. Niedziela M, Maceluch J, Korman E. Galectin-3 is not an universal marker of malignancy in thyroid nodular disease in children and adolescents. J Clin Endocrinol Meta 2002; 87 (9): 4411-4415.
17. Jarza̧b B, Gubała E, Lange D. Mikromacierze DNA i profil ekspresji genów raka brodawkowatego tarczycy. Endokrynol Pol 2005; 3: 293-301.
18. Jarza̧b B, Wiench M, Fujarewicz K i wsp. Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications. Cancer Res 2005; 65 (4): 1587-1597.